DMC Biotechnologies
PrivateLast Round
Series B
Jan 31, 2022
Total Funding Raised
$54.3M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
DMC Biotechnologies operates in Healthcare & Life Sciences and is based in Morrisville, North Carolina. Its latest recorded funding round was a Series B round in January 2022.
DMC Biotechnologies is a biotechnology company that develops bio-based specialty chemicals and ingredients using a proprietary precision fermentation technology platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Sustainable Materials, Clean Manufacturing
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
DMC Biotechnologies Comparables
Compare DMC Biotechnologies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Lygos | 87% | |
| ZymoChem | 86% | |
| Manus Bio | 83% |
For institutional investors. Book with your work email.
DMC Biotechnologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jan 31, 2022 | ||||
| Series A | Dec 16, 2019 | ||||
| Grant | Nov 18, 2019 | ||||
| Seed | Oct 8, 2018 | ||||
| Seed | Jan 9, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
DMC Biotechnologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Capricorn Partners | Series A, Series B, Seed |
| Conti Ventures | Series B |
| Breakthrough Energy Ventures | Series A, Series B, Seed |
| Sofinnova Partners | Series B, Series A |
| Boulder Ventures | Series A, Series B |
| Syensqo Ventures | Series B |
| Continental Grain Company | Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 80% MoM.
- May 4, 2026
Preparing for commercial launch of myo-inositol and d-chiro-inositol ingredients.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- receives_financingOct 26, 2026
On Oct 26th '26 in North Carolina, DMC Biotechnologies Inc. secures $18M in financing co-led by Inceptional Partners and Sofinnova Partners, with participation from First Bight Ventures, Cibus Capital, and Capricorn Partners, to accelerate KeyPura ingredient commercialization, customer adoption, and portfolio expansion.
For institutional investors. Book with your work email.
DMC Biotechnologies Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about DMC Biotechnologies's valuation, stock price, and market status.
Is DMC Biotechnologies a public or private company?
DMC Biotechnologies is a private company.
What is the current stock price of DMC Biotechnologies?
DMC Biotechnologies is a private company, so its shares have no public market price. Caplight tracks DMC Biotechnologies's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is DMC Biotechnologies worth (valuation)?
Valuation information for DMC Biotechnologies is not publicly available.
Can I buy DMC Biotechnologies stock?
DMC Biotechnologies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was DMC Biotechnologies's last funding round?
DMC Biotechnologies's most recent funding round was Series B on January 31, 2022.
Who are the main investors in DMC Biotechnologies?
Key investors in DMC Biotechnologies include Capricorn Partners, Sofinnova Partners.
Will DMC Biotechnologies IPO soon?
No public IPO plans have been announced for DMC Biotechnologies.
How can I track DMC Biotechnologies secondary market activity?
Caplight tracks bids, offers, and trades in DMC Biotechnologies's shares on secondary markets.